Fourth Quarter of Fiscal 2014 Net sales increased 4% to $94.1 million; Average Daily Sales grew 7%, excluding supply agreement Q4 FY14 GAAP loss of $0.03 per share; Non-GAAP adjusted net income, excluding amortization, of $0.18 per share Q4 FY14 Operating cash flow of $10.1 million Company introduces financial guidance for FY2015
ALBANY, N.Y., July 23, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the fourth quarter and fiscal year ended May 31, 2014.
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device
company developing and commercializing innovative interventional
treatment systems for peripheral and coronary artery disease, today
reported financial results for its fiscal fourth quarter and year ended
June 30, 2014.
ALBANY, N.Y., July 8, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2014 fourth quarter and full-year ended May 31, 2014, on Wednesday, July 23, 2014, after the close of the U.S. financial markets.
John Marshall Bank (OTCQB: JMSB) (the “Bank”) reported net income of
$3.8 million for the six months ended June 30, 2014, an increase of $425
thousand, or 12.7%, as compared to net income of $3.4 million reported
for the six months ended June 30, 2013.
HealthEquity, Inc. (NASDAQ: HQY), one of the largest HSA non-bank
custodians, today announced that the company will release the results
for its second quarter ended July 31, 2014 after the market closes on
Tuesday, September 9, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.